(Q37650181)

21 August 2017

1 reference

title

Targeting AAC-11 in cancer therapy (English)

1 reference

21 August 2017

Audrey Faye

1

1 reference

21 August 2017

Jean-Luc Poyet

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Expert Opinion on Therapeutic Targets

21 August 2017

published in

1 reference

21 August 2017

volume

14

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

57-65

1 reference

Cell death: critical control points

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Mitochondria as the central control point of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Death by design: mechanism and control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Apoptosis: controlled demolition at the cellular level

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Apoptosis and cancer: the genesis of a research field

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Apoptosis and cancer drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Prospective strategies to enforce selectively cell death in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Apoptosis and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Defects in the apoptotic machinery of cancer cells: role in drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Human ICE/CED-3 protease nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Caspases in apoptosis and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Why is cancer drug discovery so difficult?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Diagnosing and exploiting cancer's addiction to blocks in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Targeting the apoptosome for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Cutting-edge apoptosis-based therapeutics: a panacea for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

HSP27 and HSP70: potentially oncogenic apoptosis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

AAC-11 overexpression induces invasion and protects cervical cancer cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Deciphering B-ZIP transcription factor interactions in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The regulation of E2F by pRB-family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

A revised picture of the E2F transcriptional network and RB function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Sibling rivalry in the E2F family

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Regulation of the cyclin E gene by transcription factor E2F1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

E2F1 is crucial for E2F-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Direct coupling of the cell cycle and cell death machinery by E2F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Life and death decisions by the E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

21 January 2018

E2F-1 induced apoptosis

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

ATM is a target for positive regulation by E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

p14ARF links the tumour suppressors RB and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Coupling of caspase-9 to Apaf1 in response to loss of pRb or cytotoxic drugs is cell-type-specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

E2F-1-induced p53-independent apoptosis in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Role for the p53 homologue p73 in E2F-1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

p53 and E2F-1 cooperate to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

E2F1 death pathways as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Akt phosphorylation of zyxin mediates its interaction with acinus-S and prevents acinus-triggered chromatin condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Structural rationale for the coupled binding and unfolding of the c-Myc oncoprotein by small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Loss of Acinus inhibits oligonucleosomal DNA fragmentation but not chromatin condensation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Molecular cytogenetic analysis of 11 new breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Wnt/beta-catenin signaling: new (and old) players and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

X-linked inhibitor of apoptosis antagonism: strategies in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Application of XIAP antisense to cancer and other proliferative disorders: development of AEG35156/ GEM640

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

Recent advances in targeting regulators of apoptosis in cancer cells for therapeutic gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728220903431077

10.1517/14728220903431077

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference